SUPERNUS PHARMACEUTICALS, INC.·4

Feb 25, 5:24 PM ET

PATRICK GREGORY S 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 25, 2020

Insider Transaction Report

Form 4
Period: 2020-02-21
PATRICK GREGORY S
VP, Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-02-2150,00050,000 total
    Exercise: $23.99Exp: 2030-02-21Common Stock (50,000 underlying)
Holdings
  • Common Stock

    46,057
Footnotes (2)
  • [F1]Includes an aggregate of 375 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
  • [F2]The option vests in four equal annual installments beginning on February 21, 2021.

Documents

1 file
  • 4
    a4.xmlPrimary

    4